338 related articles for article (PubMed ID: 22009041)
1. Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome.
Cenini G; Dowling AL; Beckett TL; Barone E; Mancuso C; Murphy MP; Levine H; Lott IT; Schmitt FA; Butterfield DA; Head E
Biochim Biophys Acta; 2012 Feb; 1822(2):130-8. PubMed ID: 22009041
[TBL] [Abstract][Full Text] [Related]
2. Redox proteomics analysis of HNE-modified proteins in Down syndrome brain: clues for understanding the development of Alzheimer disease.
Di Domenico F; Pupo G; Tramutola A; Giorgi A; Schininà ME; Coccia R; Head E; Butterfield DA; Perluigi M
Free Radic Biol Med; 2014 Jun; 71():270-280. PubMed ID: 24675226
[TBL] [Abstract][Full Text] [Related]
3. HNE-modified proteins in Down syndrome: Involvement in development of Alzheimer disease neuropathology.
Barone E; Head E; Butterfield DA; Perluigi M
Free Radic Biol Med; 2017 Oct; 111():262-269. PubMed ID: 27838436
[TBL] [Abstract][Full Text] [Related]
4. Impairment of proteostasis network in Down syndrome prior to the development of Alzheimer's disease neuropathology: redox proteomics analysis of human brain.
Di Domenico F; Coccia R; Cocciolo A; Murphy MP; Cenini G; Head E; Butterfield DA; Giorgi A; Schinina ME; Mancuso C; Cini C; Perluigi M
Biochim Biophys Acta; 2013 Aug; 1832(8):1249-59. PubMed ID: 23603808
[TBL] [Abstract][Full Text] [Related]
5. Neuropathological role of PI3K/Akt/mTOR axis in Down syndrome brain.
Perluigi M; Pupo G; Tramutola A; Cini C; Coccia R; Barone E; Head E; Butterfield DA; Di Domenico F
Biochim Biophys Acta; 2014 Jul; 1842(7):1144-53. PubMed ID: 24735980
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease amyloid-beta links lens and brain pathology in Down syndrome.
Moncaster JA; Pineda R; Moir RD; Lu S; Burton MA; Ghosh JG; Ericsson M; Soscia SJ; Mocofanescu A; Folkerth RD; Robb RM; Kuszak JR; Clark JI; Tanzi RE; Hunter DG; Goldstein LE
PLoS One; 2010 May; 5(5):e10659. PubMed ID: 20502642
[TBL] [Abstract][Full Text] [Related]
7. Beta-amyloid, oxidative stress and down syndrome.
Lott IT; Head E; Doran E; Busciglio J
Curr Alzheimer Res; 2006 Dec; 3(5):521-8. PubMed ID: 17168651
[TBL] [Abstract][Full Text] [Related]
8. Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome.
Nunomura A; Perry G; Pappolla MA; Friedland RP; Hirai K; Chiba S; Smith MA
J Neuropathol Exp Neurol; 2000 Nov; 59(11):1011-7. PubMed ID: 11089579
[TBL] [Abstract][Full Text] [Related]
9. Down syndrome: age-dependence of PiB binding in postmortem frontal cortex across the lifespan.
LeVine H; Spielmann HP; Matveev S; Cauvi FM; Murphy MP; Beckett TL; McCarty K; Lott IT; Doran E; Schmitt F; Head E
Neurobiol Aging; 2017 Jun; 54():163-169. PubMed ID: 28385551
[TBL] [Abstract][Full Text] [Related]
10. A fibril-specific, conformation-dependent antibody recognizes a subset of Abeta plaques in Alzheimer disease, Down syndrome and Tg2576 transgenic mouse brain.
Sarsoza F; Saing T; Kayed R; Dahlin R; Dick M; Broadwater-Hollifield C; Mobley S; Lott I; Doran E; Gillen D; Anderson-Bergman C; Cribbs DH; Glabe C; Head E
Acta Neuropathol; 2009 Oct; 118(4):505-17. PubMed ID: 19360426
[TBL] [Abstract][Full Text] [Related]
11. Generation and Partial Characterization of Rabbit Monoclonal Antibody to Pyroglutamate Amyloid-β3-42 (pE3-Aβ).
Mehta PD; Patrick BA; Barshatzky M; Mehta SP; Frackowiak J; Mazur-Kolecka B; Wegiel J; Wisniewski T; Miller DL
J Alzheimers Dis; 2018; 62(4):1635-1649. PubMed ID: 29504532
[TBL] [Abstract][Full Text] [Related]
12. Relationship between proteolytically cleaved gelsolin and levels of amyloid-β protein in the brains of Down syndrome subjects.
Ji L; Chauhan V; Mehta P; Wegiel J; Mehta S; Chauhan A
J Alzheimers Dis; 2010; 22(2):609-17. PubMed ID: 20847428
[TBL] [Abstract][Full Text] [Related]
13. Microbleeds and Cerebral Amyloid Angiopathy in the Brains of People with Down Syndrome with Alzheimer's Disease.
Helman AM; Siever M; McCarty KL; Lott IT; Doran E; Abner EL; Schmitt FA; Head E
J Alzheimers Dis; 2019; 67(1):103-112. PubMed ID: 30452414
[TBL] [Abstract][Full Text] [Related]
14. An investigation of the molecular mechanisms engaged before and after the development of Alzheimer disease neuropathology in Down syndrome: a proteomics approach.
Cenini G; Fiorini A; Sultana R; Perluigi M; Cai J; Klein JB; Head E; Butterfield DA
Free Radic Biol Med; 2014 Nov; 76():89-95. PubMed ID: 25151119
[TBL] [Abstract][Full Text] [Related]
15. SOD1 (copper/zinc superoxide dismutase) deficiency drives amyloid β protein oligomerization and memory loss in mouse model of Alzheimer disease.
Murakami K; Murata N; Noda Y; Tahara S; Kaneko T; Kinoshita N; Hatsuta H; Murayama S; Barnham KJ; Irie K; Shirasawa T; Shimizu T
J Biol Chem; 2011 Dec; 286(52):44557-68. PubMed ID: 22072713
[TBL] [Abstract][Full Text] [Related]
16. Dynamics of plasma biomarkers in Down syndrome: the relative levels of Aβ42 decrease with age, whereas NT1 tau and NfL increase.
Mengel D; Liu W; Glynn RJ; Selkoe DJ; Strydom A; Lai F; Rosas HD; Torres A; Patsiogiannis V; Skotko B; Walsh DM
Alzheimers Res Ther; 2020 Mar; 12(1):27. PubMed ID: 32192521
[TBL] [Abstract][Full Text] [Related]
17. Accumulation of insoluble amyloid-β in down's syndrome is associated with increased BACE-1 and neprilysin activities.
Miners JS; Morris S; Love S; Kehoe PG
J Alzheimers Dis; 2011; 23(1):101-8. PubMed ID: 20930275
[TBL] [Abstract][Full Text] [Related]
18. Exploring Alzheimer molecular pathology in Down's syndrome cerebrospinal fluid.
Portelius E; Soininen H; Andreasson U; Zetterberg H; Persson R; Karlsson G; Blennow K; Herukka SK; Mattsson N
Neurodegener Dis; 2014; 14(2):98-106. PubMed ID: 24992945
[TBL] [Abstract][Full Text] [Related]
19. Activation of p53 in Down Syndrome and in the Ts65Dn Mouse Brain is Associated with a Pro-Apoptotic Phenotype.
Tramutola A; Pupo G; Di Domenico F; Barone E; Arena A; Lanzillotta C; Brokeaart D; Blarzino C; Head E; Butterfield DA; Perluigi M
J Alzheimers Dis; 2016; 52(1):359-371. PubMed ID: 26967221
[TBL] [Abstract][Full Text] [Related]
20. Increased amyloid beta protein levels in children and adolescents with Down syndrome.
Mehta PD; Capone G; Jewell A; Freedland RL
J Neurol Sci; 2007 Mar; 254(1-2):22-7. PubMed ID: 17275850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
